Apontis Pharma aus Monheim am Rhein hat sich insbesondere auf die Indikationen Herz-Kreislauf-Erkrankungen, Atemwegserkrankungen sowie Diabetes spezialisiert. Die Wurzeln gehen zurück auf die frühere Schwarz Pharma. Der Börsengang erfolgte im Mai 2021.
COMPANY
INVESTOR TERMSHEET
APPH/D
Apontis Pharma
#BGFL Mood:
Negative
·
#BGFL-Indicator:
Reduce
·
Review date:
31.03.2025
LEI:
894500ETO1J6MR8PDF91
SECTOR:
Gesundheit
SUB-SECTOR:
Pharma
NAME
Apontis Pharma
WKN
A3CMGM
ISIN
DE000A3CMGM5
TICKER
APPH
INDEX
EXCHANGE
Xetra
The basic chart view shows the price movement of Apontis Pharma. If you are interested in additional analysis switch to the advanced chart view.
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
Even hardened fundamentalists probably look at the chart of a share before they start analysing it in any other way. Accordingly, boersengefluester.de (BGFL) has also developed a wide range of apps relating to chart technology and sophisticated scorings with technical chart components.
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
